192 related articles for article (PubMed ID: 32250464)
1. Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.
Engbers AGJ; Flint RB; Völler S; de Klerk JCA; Reiss IKM; Andriessen P; Liem KD; Degraeuwe PLJ; Croubels S; Millecam J; Allegaert K; Simons SHP; Knibbe CAJ
Br J Clin Pharmacol; 2020 Oct; 86(10):2028-2039. PubMed ID: 32250464
[TBL] [Abstract][Full Text] [Related]
2. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
[TBL] [Abstract][Full Text] [Related]
3. Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?
Smit C; Engbers AGJ; Samiee-Zafarghandy S; van Donge T; Simons SHP; Flint RB; Pfister M; Knibbe CAJ; van den Anker JN
Neonatology; 2023; 120(1):81-89. PubMed ID: 36502794
[TBL] [Abstract][Full Text] [Related]
4. Chiral pharmacokinetics of ibuprofen enantiomers in Chinese preterm neonates with patent ductus arteriosus using a validated UHPLC-MS/MS method.
Xiao D; Jin Y; Zhang M; Di X; Fu L; Jiang C; Lai Z; Ge Y; Ji S; Zhang Y; Zheng L; Wang Z; Gong F
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jul; 1227():123765. PubMed ID: 37454407
[TBL] [Abstract][Full Text] [Related]
5. Ibuprofen treatment after the first days of life in preterm neonates with patent ductus arteriosus.
de Klerk JCA; van Paassen N; van Beynum IM; Flint RB; Reiss IKM; Simons SHP
J Matern Fetal Neonatal Med; 2021 Aug; 34(15):2411-2417. PubMed ID: 31510826
[TBL] [Abstract][Full Text] [Related]
6. Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns.
Flint RB; Ter Heine R; Spaans E; Burger DM; de Klerk JCA; Allegaert K; Knibbe CAJ; Simons SHP
Eur J Clin Pharmacol; 2018 Dec; 74(12):1585-1591. PubMed ID: 30054639
[TBL] [Abstract][Full Text] [Related]
7. Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates.
Samiee-Zafarghandy S; van Donge T; Fusch G; Pfister M; Jacob G; Atkinson A; Rieder MJ; Smit C; Van Den Anker J
Arch Dis Child; 2022 Jan; 107(1):86-91. PubMed ID: 33975823
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants.
Engbers AGJ; Völler S; Flint RB; Goulooze SC; de Klerk J; Krekels EHJ; van Dijk M; Willemsen SP; Reiss IKM; Knibbe CAJ; Simons SHP
Clin Pharmacol Ther; 2022 Aug; 112(2):307-315. PubMed ID: 35429165
[TBL] [Abstract][Full Text] [Related]
9. Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen.
Cristea S; Allegaert K; Falcao AC; Falcao F; Silva R; Smits A; Knibbe CAJ; Krekels EHJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182538
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.
Van Overmeire B; Touw D; Schepens PJ; Kearns GL; van den Anker JN
Clin Pharmacol Ther; 2001 Oct; 70(4):336-43. PubMed ID: 11673749
[TBL] [Abstract][Full Text] [Related]
13. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?
Akar M; Yildirim TG; Sandal G; Bozdag S; Erdeve O; Altug N; Uras N; Oguz SS; Dilmen U
Cardiol Young; 2017 Apr; 27(3):507-511. PubMed ID: 27319277
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
Gouyon JB; Kibleur Y
Clin Ther; 2010 Sep; 32(10):1740-8. PubMed ID: 21194597
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of ibuprofen enantiomers in very premature neonates.
Gregoire N; Gualano V; Geneteau A; Millerioux L; Brault M; Mignot A; Roze JC
J Clin Pharmacol; 2004 Oct; 44(10):1114-24. PubMed ID: 15342612
[TBL] [Abstract][Full Text] [Related]
17. The bioavailability and maturing clearance of doxapram in preterm infants.
Flint RB; Simons SHP; Andriessen P; Liem KD; Degraeuwe PLJ; Reiss IKM; Ter Heine R; Engbers AGJ; Koch BCP; Groot R; Burger DM; Knibbe CAJ; Völler S;
Pediatr Res; 2021 Apr; 89(5):1268-1277. PubMed ID: 32698193
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral versus intravenous ibuprofen for closure of patent ductus arteriosus: A pilot randomised controlled study.
Edison PE; Chen S; Yeo CL; Allen JC; Poon WB; Baral VR; Chowbay B
J Paediatr Child Health; 2022 Mar; 58(3):397-403. PubMed ID: 34477275
[TBL] [Abstract][Full Text] [Related]
20. Reopening of the ductus arteriosus in preterm infants; Clinical aspects and subsequent consequences.
Halil H; Buyuktiryaki M; Atay FY; Oncel MY; Uras N
J Neonatal Perinatal Med; 2018; 11(3):273-279. PubMed ID: 30149471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
